Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oscar Lin

Showing results (111-120 of 141) with videos related to

Pageof 15
Sort By:
Journal of Pathology Informatics|October 9, 2023
Digital pathology operations at a tertiary cancer center: Infrastructure requirements and operational costOrly Ardon, Eric Klein, Allyne Manzo, et al.
Cancer Cytopathology|April 22, 2026
Ultrarapid BRAF mutation detection on supernatant cell-free DNA obtained by FNA: An accurate and expedient method for BRAF assessment in aggressive thyroid carcinomasJose Manuel Gutierrez Amezcua, Maria E Arcila, Dianna L Ng, et al.
Thyroid : Official Journal of the American Thyroid Association|December 18, 2013
Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS)Allen S Ho, Evan E Sarti, Kunal S Jain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancerDavid R Shaffer, Margaret A Leversha, Daniel C Danila, et al.
Cancer Cytopathology|May 31, 2022
Multi-institutional validation of a modified scheme for subcategorizing salivary gland neoplasm of uncertain malignant potential (SUMP)Jen-Fan Hang, Jaslyn Jie Lin Lee, Min En Nga, et al.
American Journal of Clinical Pathology|September 11, 2021
Global Cytopathology-Hematopathology Practice TrendsSara L Zadeh, Ronald Balassanian, Matthew C Cheung, et al.
Surgery|October 27, 2018
Interinstitutional variation in predictive value of the ThyroSeq v2 genomic classifier for cytologically indeterminate thyroid nodulesAndrea R Marcadis, Pablo Valderrabano, Allen S Ho, et al.
Urologic Oncology|August 28, 2023
Feasibility and tissue concordance of genomic sequencing of urinary cytology in upper tract urothelial carcinomaAndrew B Katims, Christopher Gaffney, Sanaz Firouzi, et al.
The Journal of Pathology|May 7, 2011
Somatic mutation of fibroblast growth factor receptor-3 (FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinomaHikmat A Al-Ahmadie, Gopa Iyer, Manickam Janakiraman, et al.
Frontiers in Oncology|June 21, 2024
Performance of <i>MYC</i>, <i>BCL2</i>, and <i>BCL6</i> break-apart FISH in small biopsies with large B-cell lymphoma: a retrospective Cytopathology Hematopathology Interinstitutional Consortium studyJoshua R Menke, Umut Aypar, Charles D Bangs, et al.
Pageof 15

Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
Journal of Pathology Informatics|October 9, 2023
Digital pathology operations at a tertiary cancer center: Infrastructure requirements and operational costOrly Ardon, Eric Klein, Allyne Manzo, et al.
Cancer Cytopathology|April 22, 2026
Ultrarapid BRAF mutation detection on supernatant cell-free DNA obtained by FNA: An accurate and expedient method for BRAF assessment in aggressive thyroid carcinomasJose Manuel Gutierrez Amezcua, Maria E Arcila, Dianna L Ng, et al.
Thyroid : Official Journal of the American Thyroid Association|December 18, 2013
Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS)Allen S Ho, Evan E Sarti, Kunal S Jain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancerDavid R Shaffer, Margaret A Leversha, Daniel C Danila, et al.
Cancer Cytopathology|May 31, 2022
Multi-institutional validation of a modified scheme for subcategorizing salivary gland neoplasm of uncertain malignant potential (SUMP)Jen-Fan Hang, Jaslyn Jie Lin Lee, Min En Nga, et al.
American Journal of Clinical Pathology|September 11, 2021
Global Cytopathology-Hematopathology Practice TrendsSara L Zadeh, Ronald Balassanian, Matthew C Cheung, et al.
Surgery|October 27, 2018
Interinstitutional variation in predictive value of the ThyroSeq v2 genomic classifier for cytologically indeterminate thyroid nodulesAndrea R Marcadis, Pablo Valderrabano, Allen S Ho, et al.
Urologic Oncology|August 28, 2023
Feasibility and tissue concordance of genomic sequencing of urinary cytology in upper tract urothelial carcinomaAndrew B Katims, Christopher Gaffney, Sanaz Firouzi, et al.
The Journal of Pathology|May 7, 2011
Somatic mutation of fibroblast growth factor receptor-3 (FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinomaHikmat A Al-Ahmadie, Gopa Iyer, Manickam Janakiraman, et al.
Frontiers in Oncology|June 21, 2024
Performance of <i>MYC</i>, <i>BCL2</i>, and <i>BCL6</i> break-apart FISH in small biopsies with large B-cell lymphoma: a retrospective Cytopathology Hematopathology Interinstitutional Consortium studyJoshua R Menke, Umut Aypar, Charles D Bangs, et al.
Pageof 15